TRACON Pharmaceuticals, Inc. appointed Mark Wiggins as chief business officer, effective May 30.
Wiggins has previously served as senior vice president of corporate and business development at San Diego-based Elcelyx Therapeutics Inc.
TRACON Pharmaceuticals appoints chief business officer
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
TRACON Pharmaceuticals, Inc. appointed Mark Wiggins as chief business officer, effective May 30.
Wiggins has previously served as senior vice president of corporate and business development at San Diego-based Elcelyx Therapeutics Inc.